With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

In a recent retrospective and observational cohort study published in The Lancet Infectious Diseases, researchers examine non-hospitalized adult patients with coronavirus disease 2019 (COVID-19) ...

The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen. COVID-19 is ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

Starting point: nirmatrelvir/ritonavir (Paxlovid) used to work very well. In 2021, nirmatrelvir/ritonavir clearly decreased hospitalization and death among COVID-19 patients who had high risks of ...

Discover comprehensive details about Lopinavir and Ritonavir, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Please provide your email address to receive an email when new articles are posted on . There are drug-drug interactions between the COVID-19 treatment ritonavir/nirmatrelvir and various classes of ...

Darunavir is a new protease inhibitor (PI) active against wild-type and drug-resistant HIV-1 strains and has recently been approved for use in treatment-experienced adult patients. The main clinical ...

New research highlights the effectiveness of nirmatrelvir-ritonavir in lowering hospitalization rates and long COVID symptoms in non-hospitalized, high-risk COVID-19 patients. Study: Nirmatrelvir plus ...

Discover comprehensive details about Atazanavir and Ritonavir, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...